06/11/2026
I wanted to briefly touch on a clip that has been making the rounds on social media. It features Bryan Ardis, who is a chiropractor, speaking with podcast host Rebecca Weiss about GLP-1 medications like Ozempic and Wegovy.
Link: https://www.facebook.com/share/v/1HZXcf6FDM/?mibextid=wwXIfr
The problem with the clip is that he is not really addressing the fair concerns about these medications. There are real things to discuss with GLP-1 medications: nausea, vomiting, constipation, gallbladder disease, pancreatitis risk, muscle loss if patients are not getting enough protein or resistance training, cost, supply issues, and weight regain if the medication is stopped without sustainable lifestyle changes. Those are fair concerns.
Instead, he builds a misleading argument around what these medications are made from.
First, he says there is “no GLP-1” in Ozempic or Wegovy. That is technically true, but it is misleading. Ozempic and Wegovy contain semaglutide, which is a GLP-1 receptor agonist. That means it is designed to activate the same receptor as your body’s natural GLP-1 hormone. Semaglutide is not the exact native GLP-1 hormone, because native GLP-1 is broken down very quickly in the body. The medication was modified so that it lasts much longer. This is common in medicine. We often modify natural hormones or peptides to make them last longer or work more predictably. Examples include long-acting insulin analogs, long-acting testosterone esters, and other modified peptide or hormone-based medications.
Second, he suggests that Ozempic or Wegovy contain exendin-4 from Gila monster venom. That is not correct. Exendin-4 is a real peptide that was originally identified from the Gila monster, and it led to the development of exenatide, which is an older GLP-1 medication sold as Byetta or Bydureon. But Ozempic and Wegovy are not exenatide. They are semaglutide. Semaglutide is a modified analog of human GLP-1, not Gila monster venom.
There is also a broader point here. Many medications have been developed from compounds first identified in plants, bacteria, fungi, animals, or venoms. That does not automatically make them dangerous. ACE inhibitors, for example, were developed after research involving snake venom peptides. Digoxin comes from foxglove. Penicillin came from mold. The source of a discovery does not determine whether a medication is safe or unsafe. What matters is the actual molecule, the dose, and how it behaves in the body.
The phrase “the dose makes the poison” is important here. Venom contains many different compounds. Scientists may identify one specific peptide from that mixture, study it, modify it, purify it, and turn it into a medication. That is very different from injecting venom. Presenting it as “this comes from venom” without explaining that distinction is fear-based and misleading.
So my main concern with the clip is not that GLP-1 medications are perfect. They are not. They have side effects. They are not appropriate for every patient. They should be used with attention to nutrition, protein intake, strength training, long-term planning, and medical monitoring.
But the argument in this clip is not a serious discussion of those real risks. It is mostly using technical-sounding claims to create fear. The accurate summary is this: Ozempic and Wegovy do not contain native GLP-1, and they do not contain Gila monster venom. They contain semaglutide, a GLP-1 receptor agonist designed to activate the GLP-1 receptor and last longer than the body’s natural GLP-1 hormone.
This post is for educational purposes only and does not constitute medical advice. Talk to your doctor before making any decisions about testing or treatment.*